Skip to main content
OpenTrials

Clinical trial condition

Endometrial Neoplasms

Explore clinical trials studying Endometrial Neoplasms. Study availability and eligibility vary by location and protocol.

1,023 public trials 304 recruiting studies
Refine in advanced search Browse all conditions

Endometrial Neoplasms trial results

Recruiting

Individualised Endometrial Cancer Risk Stratification by Bayesian Prediction Model (ENDORISK), Optimizing Clinical Implementation

NCT07200466

Conditions
Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +15 more
Locations
  • Rijnstate Arnhem, Gelderland, Netherlands
  • Slingeland Hospital Doetinchem, Gelderland, Netherlands
  • Gelderse Vallei Ede, Gelderland, Netherlands
  • Radboudumc Nijmegen, Gelderland, Netherlands
View all 14 locations
View Trial Details
Recruiting

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

NCT07503808

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +48 more
Locations
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • START New York Long Island, LLC Lake Success, New York, United States
View all 15 locations
View Trial Details
Recruiting

Non-Invasive Identification of Endometrial Cancer/Endometrial Atypical Hyperplasia With an AI-Based Classifier Applied to Transvaginal Ultrasound in Patients With Post-Menopausal Bleeding

NCT06365905

Conditions
Endometrial Carcinoma, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
View Trial Details
Recruiting

A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types

NCT04300556

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Diseases, +33 more
Locations
  • ACRC/Arizona Clinical Research Center, Inc Tucson, Arizona, United States
  • Universty of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Stanford Women's Cancer Center Palo Alto, California, United States
  • University of Miami Coral Gables, Florida, United States
View all 58 locations
View Trial Details

Related conditions